(Q36939711)

17 August 2017

1 reference

title

The role of nitric oxide in osteoarthritis (English)

1 reference

17 August 2017

1 reference

Vuolteenaho K

1

1 reference

17 August 2017

Moilanen T

series ordinal

2

1 reference

17 August 2017

Knowles RG

series ordinal

3

1 reference

17 August 2017

Moilanen E

series ordinal

4

1 reference

17 August 2017

1 July 2007

1 reference

Scandinavian Journal of Rheumatology

17 August 2017

1 reference

17 August 2017

36

1 reference

17 August 2017

4

1 reference

17 August 2017

247-258

1 reference

Clinical practice. Osteoarthritis of the knee

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide synthases: structure, function and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Purification and characterization of a nitric-oxide synthase from rat liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Mitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Cloning and characterization of inducible nitric oxide synthase from mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Regulation of the expression of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide production and signaling in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Molecular mechanisms regulating iNOS expression in various cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3'untranslated region of the murine inducible nitric-oxide synthase mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Ubiquitination of inducible nitric oxide synthase is required for its degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

TGF-beta1 enhances degradation of IFN-gamma-induced iNOS protein via proteasomes in RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

TGFbeta inhibits IL-1 -induced iNOS expression and NO production in immortalized chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Does nitric oxide modulate mitochondrial energy generation and apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Novel effects of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitrosylation. the prototypic redox-based signaling mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Peroxynitrite and drug-dependent toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Mitochondrial proteomics in free radical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Progress in the development of selective nitric oxide synthase (NOS) inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Blocking NO synthesis: how, where and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of ch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Is nitric oxide overproduction the target of choice for the management of septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide signaling in colon cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

NO signaling in the CNS: from the physiological to the pathological

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Corticosteroid injections for osteoarthritis of the knee: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Guidelines for the management of rheumatoid arthritis: 2002 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Detection of nitrotyrosine in aging and osteoarthritic cartilage: Correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Influence of oxygen tension on nitric oxide and prostaglandin E2 synthesis by bovine chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Tyrosine kinases are involved with the expression of inducible nitric oxide synthase in human articular chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Apoptosis of chondrocytes in transgenic mice lacking collagen II

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

21 January 2018

Cell death in cartilage.

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

The role of reactive oxygen species in homeostasis and degradation of cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Oxygen and reactive oxygen species in cartilage degradation: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Suppression of arthritis by an inhibitor of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Modulation of adjuvant arthritis by endogenous nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orall

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Differential function of nitric oxide in murine antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Development of lyme arthritis in mice deficient in inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Animal models of arthritis in NOS2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

Nitric-Oxide Mediates Suppression of Cartilage Proteoglycan Synthesis by Interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701483014

10.1080/03009740701483014

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference